Nanjing Pharmaceutical announced that it plans to change the purpose of repurchasing 39,900 shares in 2025 from “for employee stock ownership plans or share incentives” to “to cancel and reduce registered capital.”

Zhitongcaijing · 2d ago
Nanjing Pharmaceutical announced that it plans to change the purpose of repurchasing 39,900 shares in 2025 from “for employee stock ownership plans or share incentives” to “to cancel and reduce registered capital.”